Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Seulki Lee
AddedMar 31, 2024
UpdatedMay 31, 2026
Seulki Lee

Seulki Lee

Co-Founder & CEO, D&D Pharmatech

CrunchbaseLinkedIn

Seulki Lee's Career

D&D Pharmatech
D&D Pharmatech

Germantown, MD, US

Co-Founder & CEO· C-Suite · Management
Theraly Pharmaceuticals
Theraly Pharmaceuticals

Baltimore, MD, US

Co-Founder & CEO· C-Suite · Management
Valted Seq
Valted Seq

Gaithersburg, MD, US

Board Member· Board
Neuraly
Neuraly

Germantown, MD, US

Co-Founder & CEO· C-Suite · Management

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Seulki Lee's Career

D&D Pharmatech
D&D Pharmatech
Public$233.6M112014Germantown, MD, US
Co-Founder & CEO· C-Suite · Management

Similar to D&D Pharmatech

Blade TherapeuticsBlade TherapeuticsSouth San Francisco, CA, USDrug Developmentest. 2013Blade TherapeuticsSouth San Francisco, CA, US · est. 2013

Blade Therapeutics: A US-based biopharmaceutical company specializing in fibrosis treatment and drug development.

Series D · $51.5M28
Moerae MatrixMoerae MatrixMorristown, NJ, USTherapeuticsest. 2007Moerae MatrixMorristown, NJ, US · est. 2007

US-based Moerae Matrix develops first-in-class targeted therapeutics for fibrotic diseases.

Angel · $5.8M11
SphynKx TherapeuticsSphynKx TherapeuticsCharlottesville, VA, USBiotechnology, Therapiesest. 2010SphynKx TherapeuticsCharlottesville, VA, US · est. 2010

SphynKx Therapeutics: Innovating biotech solutions for cancer and fibrosis treatment.

Seed · $50k30
Indalo TherapeuticsIndalo TherapeuticsSt. Louis, MO, USBiotechest. 2014Indalo TherapeuticsSt. Louis, MO, US · est. 2014

Indalo Therapeutics: A preclinical-stage biotech firm developing therapies for debilitating fibrotic diseases.

Series A · $9.8M11
Theraly Pharmaceuticals
Theraly Pharmaceuticals
Seed$200k72013Baltimore, MD, US
Co-Founder & CEO· C-Suite · Management

Leadership at Theraly Pharmaceuticals

Justin HanesJustin HanesCo-Founder
Martin G. PomperMartin G. PomperCo-Founder
Kang Choon LeeKang Choon LeeCo-Founder
Mark RampyMark RampyCo-Founder
Valted Seq
Valted Seq
Seed$12.5M322019Gaithersburg, MD, US
Board Member· Board

Leadership at Valted Seq

Mohammad N. RanjbarMohammad N. RanjbarCEO
Valina DawsonValina DawsonCo-Founder
Ted DawsonTed DawsonCo-Founder

Similar to Valted Seq

SelonterraSelonterraSan Mateo, CA, USDiagnostics, Therapeuticsest. 2017SelonterraSan Mateo, CA, US · est. 2017

Selonterra: A venture-backed biopharmaceutical firm in SF, specializing in Alzheimer's and Parkinson's therapies.

Seed · $2.5M8
Vesalius TherapeuticsVesalius TherapeuticsCambridge, MA, USDrug Developmentest. 2019Vesalius TherapeuticsCambridge, MA, US · est. 2019

Vesalius Therapeutics: Innovating drug development to combat major human illnesses.

Series A · $75M35
Denali TherapeuticsDenali TherapeuticsSan Francisco, CA, USBiotechest. 2015Denali TherapeuticsSan Francisco, CA, US · est. 2015

Denali Therapeutics, a US-based biotech firm, develops medicines for neurodegenerative diseases.

Public · $622M427
Vanqua BioVanqua BioChicago, IL, USDrug Developmentest. 2019Vanqua BioChicago, IL, US · est. 2019

Vanqua Bio: Innovating neurodegenerative disease treatment through genetics-based drug development.

Series B · $85M33
Neuraly
Neuraly
Series A$36M1252016Germantown, MD, US
Co-Founder & CEO· C-Suite · Management

Leadership at Neuraly

Zoltan MariZoltan MariCo-Founder
Viktor RoschkeViktor RoschkeBoard Member

Seulki Lee's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGBoard Member · DiDi

People Similar to Seulki Lee

Philip ArlenPhilip ArlenCEO · Precision BiologicsW. David LeeW. David LeeCo-Founder · LumicellDavid KelsoDavid KelsoCo-Founder & CEO · Minute Molecular DiagnosticsMichael AmorosoMichael AmorosoBoard Member · Abeona TherapeuticsBharath RaoBharath RaoCo-Founder · DataNeuronTarek Ali ZakiTarek Ali ZakiCo-Founder · OncoPrecision